Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer

JSON

Moskov M, Hedlund JL, Popova S, Lycke M, Ivansson E, Tolf A, Gyllensten U, Sundfeldt K, Stålberg K, Enroth S

- - (-) - [2024-10-10; online 2024-10-10]

DOI 10.1101/2024.10.10.24315232

Crossref 10.1101/2024.10.10.24315232